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Abstract Dyslipidemia, in£ammation and gender are major
risk factors in cardiovascular disease. Here we show that hepat-
ic expression of Peroxisome proliferator-activated receptor K
(PPARK), a nuclear receptor that regulates lipid metabolism
and in£ammation, is regulated in a gender-speci¢c manner dur-
ing lipopolysaccharide (LPS)-induced systemic in£ammation.
Immediately following LPS-induced systemic in£ammation, he-
patic PPARK mRNA level decreased dramatically in mice. It
was restored to baseline within 24 h in females but remained
below baseline for s 72 h in male mice. In gonadectomized mice
of both sexes, PPARK mRNA level was restored to baseline
within 48 h after the initial decrease.
. 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Peroxisome proliferator-activated receptor K (PPARK) is a
member of the large steroid/thyroid/retinoid nuclear receptor
superfamily, distinguished by its hallmark DNA binding do-
main of two zinc ¢nger-like motifs that recognizes DNA re-
sponse elements consisting of two copies of a core motif. The
canonical DNA response element that binds PPARK is known
as peroxisome proliferator response element (PPRE) and con-
sists of two hexanucleotides with the consensus sequence
AGGTCA separated by a single nucleotide spacer. When ac-
tivated by ligand binding and/or phosphorylation, PPARK
undergoes conformational changes to recruit coactivator com-
plexes for transcription of target genes. Like other PPARs,
activated PPARK heterodimerizes with retinoid X receptor
for binding to PPREs (reviewed in [1,2]).
PPARK plays a signi¢cant role in lipid metabolism by reg-
ulating expression of catabolic enzymes, structural proteins
and transport proteins that are involved in mitochondrial
and peroxisomal L-oxidation, microsomal g-oxidation, cellu-
lar fatty acid uptake and e¥ux, lipoprotein metabolism etc.
PPARK can be activated by a wide variety of naturally oc-
curring fatty acids and eicosanoids, endogenous agonists
composed of polyunsaturated fatty acids (e.g. K-linoleic, Q-
linolenic, arachidonic and eicosapentaenoic acids) and me-
dium-chain saturated and monounsaturated fatty acids (e.g.
palmitic and oleic acids, leukotriene B4 (LTB4) and
8(S)HETE)) (reviewed in [1^6]).
PPARK is also implicated in the development and intensity
of in£ammatory responses. This role appears to be multi-fac-
eted and intimately linked to its role as a regulator of lipid
metabolism and its activation by in£ammatory ligands such as
LTB4 (reviewed in [7]). Consistent with this, PPARK null mice
have prolonged in£ammatory responses than their wild-type
littermates in response to LTB4 [8]. PPARK agonists such as
feno¢brates have been shown to modulate mediators of in-
£ammation such as NFUB, IUBa, plasma interleukin (IL)-6
concentration and plasma tumor necrosis factor-K (TNF-K)
level [9].
As a key regulator of lipid metabolism, PPARK is a major
molecular target for treating hypertriglyceridemia as part of a
therapeutic strategy to reduce cardiovascular risk. PPARK
agonists such as the ¢brates have proven to be therapeutically
e¡ective in managing hypertriglyceridemia and reducing car-
diovascular risk [10^12]. The role of PPARK in the molecular
pathogenesis of cardiovascular disease is likely to be e¡ected
through a multi-factorial mechanism that includes its role in
lipid metabolism, and both systemic and local in£ammation.
Incidentally, cardiovascular disease itself is a disease of com-
plex etiology, and dyslipidemia and in£ammation are two
major causative factors [13].
To better understand the role of PPARK in cardiovascular
disease, we examined the regulation of hepatic PPARK ex-
pression during systemic in£ammation in male and female
mice. A previous report has indicated that PPARK is a limit-
ing factor and that PPARK expression levels have a direct
impact on the regulation of its target genes [14]. Therefore,
regulating PPARK expression level is as critical as activating
the receptor itself. The examination of hepatic PPARK expres-
sion during systemic in£ammation in male and female would
provide insights into gender-speci¢c lipid regulation during
in£ammation in the major organ of lipid metabolism and a
major response organ in systemic in£ammation. Like dyslip-
idemia and in£ammation, the male gender is also an impor-
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tant risk factor in cardiovascular disease [13]. Indeed, we have
previously shown that expression of several genes known to
be important in cardiovascular disease, such as angiotensin
converting enzyme (ACE), high density lipoprotein-associated
antioxidant and paraoxonase-1, is regulated in a gender-spe-
ci¢c manner [15,16].
2. Materials and methods
2.1. Animals
All animal experimentations were carried out in accordance with
the guiding principles for animal research as speci¢ed by the Animal
Ethics Committee of the National University of Singapore and have
been previously described [15]. Brie£y, systemic in£ammation was
induced in intact and gonadectomized C57BL/6J mice with lipopoly-
saccharide (LPS), and liver RNA was prepared at 0, 2, 4, 6, 24, 48 and
72 h.
2.2. Northern analysis
Total RNA was prepared by homogenizing tissues in guanidine
isothiocyanate bu¡er and puri¢cation over a CsCl gradient as previ-
ously described [17]. The RNA was analyzed by Northern blot anal-
ysis. Brie£y, 10 mg of total RNA was denatured by glyoxal, separated
on an agarose gel, transferred onto a nylon membrane and probed
with random-primed, 32P-labelled DNA fragments as previously de-
scribed [17]. Signal intensity was analyzed by phosphorimaging. Glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) was used for nor-
malizing variations in RNA loading between samples. The probes
used were reverse transcription (RT)-PCR products that were gener-
ated using the following sets of primers: (1) PPARK 5P-ACGG-
CAATGGCTTTATCACAC-3P and 5P-CTACGCTCAGCCCTCTT-
CATC-3P (420 bp), (2) GAPDH 5P-GGCAAATTCAACGGCAC-
AGTC-3P and 5P-CTGTTATTATGGGGGTCTGGG-3P (967 bp),
(3) serum amyloid A protein (SAA) 5P-ATCACGTGATGCAAGA-
GAGAGC-3P and 5P-ATTACCCTCTCCTCCTCAAGC-3P (269 bp),
(4) serum amyloid P protein (SAP) 5P-TGTTTGTCTTCACCAGCC-
TTC-3P and 5P-GTGAACTCTGCCGCCGCCTTGACC-3P (406 bp),
(5) IL-1L 5P-AAGATGTCCAACTTCACCTTCAAGGAGAGCCG-
3P and 5P-AGGTCGGTCTCACTACCTGTGATGAGTTTTGG-3P
(491 bp), (6) IL-6 5P-ATGAAGTTCCTCTCTGCAAGAGAC-3P
and 5P-CACTAGGTTTGCCGAGTAGATCTC-3P (638 bp), (7)
TNF-K 5P-TTCTGTCTACTGAACTTCGGGGTGATCGGTCC-3P
and 5P-GTATGAGATAGCAAATCGGCTGACGGTGTGGG-3P
(354 bp). RT-PCR was carried out as previously described [18].
2.3. Hepa cell culture
Hepa cells (a gift from Heinz Baumann) were cultured in Dulbecco
minimal essential media with 10% fetal calf serum. The cells
were treated with (a) 10 Wg/ml LPS, (b) 1 mM dexamethasone or
(c) 10 Wg/ml LPS and 1 mM dexamethasone for 0, 2, 4, 6, 24 and
48 h. Total RNA was prepared and analyzed by Northern blot hy-
bridization.
3. Results
3.1. Regulation of PPARK expression in a gender-speci¢c
manner during systemic in£ammation
PPARK mRNA was easily detectable in the livers of male
and female mice (Fig. 1a,b). Within 2 h of inducing systemic
in£ammation by LPS, PPARK mRNA levels declined more
than 50% in both male and female mice. In female mice,
PPARK mRNA level recovered to baseline level within 24 h.
It remained slightly but not signi¢cantly elevated above base-
Fig. 1. Analysis of hepatic RNA from LPS-treated mice. a: Northern analysis for PPARK mRNA. The blot shown was representative of four
independent experiments. Each Northern blot membrane was probed with 32P-labelled PPARK and GAPDH-speci¢c probes. b: Relative PPARK
mRNA levels. PPARK signals were quantitated by phosphorimaging and normalized to that of GAPDH. The normalized PPARK mRNA level
in male mice at 0 h was designated 1. Data represent means of four independent experimentsS S.E.M.. c,d: Assessment of systemic in£amma-
tion by Northern blot analysis. The hepatic RNA was also analyzed for acute phase reactants such as SAA, SAP and cytokines such as TNF-
K, IL-1L and IL-2.
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line for up to 72 h. In contrast, PPARK mRNA level in male
mice failed to recover to baseline level 72 h after induction of
systemic in£ammation. To ensure that the magnitude of the
induced systemic in£ammation in both sexes was equivalent,
IL-1, IL-6, TNF-K, SAA and SAP mRNA levels were moni-
tored (Fig. 1c,d). When normalized against GAPDH mRNA
level, there was no di¡erence in the induction between male
and female mice.
3.2. Gonadectomy attenuates regulation of PPARK mRNA
during systemic in£ammation
The above experiment was repeated in gonadectomized
mice. Like the intact animals, PPARK mRNA in gonadectom-
ized animals also decreased within 4 h after LPS challenge
(Fig. 2a,b). However, PPARK mRNA levels in both male
and female gonadectomized mice were restored to baseline
within 48 h and were not signi¢cantly di¡erent between go-
nadectomized male and female animals. Gonadectomy not
only abolished the sexual dimorphism seen in intact animals,
it also moderated LPS-induced changes in PPARK mRNA
level in both male and female gonadectomized mice to that
intermediate between those in intact males and females (Fig.
2b). Unlike PPARK mRNA, the induction of SAA, SAP,
IL-1L, IL-6 and TNF-K mRNA levels during LPS challenge
was not altered by gonadectomy (Fig. 2c,d).
3.3. LPS did not a¡ect PPARK expression in Hepa cells
To determine if LPS exerted a direct e¡ect on PPARK gene
expression, Hepa cells, a mouse hepatoma cell line, were
treated with LPS. When treated with dexamethasone, PPARK
mRNA level increased 10-fold elevation, as expected
[14,19,20]. However, LPS alone had no e¡ect on PPARK
mRNA in Hepa cells but it had a synergistic e¡ect on dexa-
methasone-mediated increase in PPARK mRNA level (Fig. 3).
Fig. 2. Analysis of hepatic RNA from LPS-treated gonadectomized mice. a: Northern analysis for PPARK mRNA. The blot shown was repre-
sentative of four independent experiments. Each Northern blot membrane was probed with 32P-labelled PPARK and GAPDH-speci¢c probes.
b: Relative PPARK mRNA levels. PPARK signals were quantitated by phosphorimaging and normalized to that of GAPDH. The normalized
PPARK mRNA level in male mice at 0 h was designated 1. Data represent means of four independent experimentsS S.E.M. c,d: Assessment of
systemic in£ammation by Northern blot analysis. The hepatic RNA was also analyzed for acute phase reactants such as SAA, SAP and cyto-
kines such as TNF-K, IL-1L and IL-2.
Fig. 3. E¡ects of LPS and dexamethasone on PPARK mRNA level in Hepa cells. The cells were treated with 10 Wg/ml LPS, 1 mM dexametha-
sone or both for 0, 2, 4, 6, 24 and 48 h. Total RNA was prepared and analyzed on Northern blot assay.
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4. Discussion
Our study demonstrated that PPARK expression in the liver
was regulated in a gender-speci¢c manner during LPS-induced
in£ammation. Gonadectomy abolished the gender di¡erences.
Gonadectomized male and female mice exhibited an attenu-
ated female gene expression pattern during in£ammation, sug-
gesting that the female gene expression pattern is the default
pattern and that the male gonads had a dominant e¡ect on
the expression pattern while the female gonads may enhance
expression. We have previously demonstrated that in the con-
ventional housing system of ¢ve adult male mice to a cage,
serum testosterone in all the male mice except the dominant
male is equivalent to that in the female mice and the dominant
mice have a serum testosterone level that is at least an order
higher [15,16]. Therefore, the male gonadal e¡ect on PPARK
expression was not likely to be mediated by serum testoster-
one level.
PPARK expression in liver has previously been reported to
be regulated by physiological situations such as the diurnal
surge of glucocorticoids a¡ects [14], and the secretion of glu-
cocorticoids by the hypothalamus-pituitary-adrenal axis dur-
ing in£ammation has long been recognized as gender-speci¢c
with females generally secreting higher levels of glucocorti-
coids during in£ammation including LPS-induced in£amma-
tion ([21] ; reviewed in [22]). We also demonstrated that LPS
accentuated upregulation of PPARK expression by dexame-
thasone. Together this suggested that the more rapid recovery
of PPAR mRNA level to baseline in female mice during in-
£ammation was likely to be mediated by the higher secretion
of glucocorticoids in female mice.
In summary, our study demonstrated that PPAR expression
in the liver is regulated in a gender-speci¢c manner during
in£ammation. Since the liver is the major organ for lipid
metabolism, and PPARK is limiting with ligand binding ac-
tivity directly correlated to its mRNA level [14], the immedi-
ate implication of our study is that lipid metabolism during
in£ammation is regulated in a gender-speci¢c manner during
in£ammation. In addition, we have identi¢ed a candidate mol-
ecule that could provide a common underlying molecular
mechanism for three major risk factors in cardiovascular dis-
ease, namely gender, in£ammation and dyslipidemia [13].
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